Regents of The University of Minnesota

What Regents of The University of Minnesota does

The Regents of The University of Minnesota is the constitutionally autonomous governing entity of a public, land-grant research university founded in 1851, operating five campuses (Crookston, Duluth, Morris, Rochester, and Twin Cities) with a workforce of 5,001–10,000 and a proposed FY2026-27 operating budget of $5.4 billion. The university delivers undergraduate, graduate, and professional education; conducts research across agriculture (e.g., MN-Amber oat variety), biomedicine, microelectronics, and AI; runs clinical services through M Health Fairview; and licenses proprietary technologies such as the CounterXCL monoclonal antibody platform (licensed to CounterX Therapeutics) and the GTB-5550 camelid nanobody therapy (in Phase 1a/1b with GT Biopharma, $3.8M over three years).

The institution monetizes through a multi-stream model: state appropriations, tuition and fees (with a proposed 3.8% undergraduate increase for the sixth consecutive year), sponsored research and licensing royalties, athletic sponsorships (including a 10-year, $17M naming rights deal with Blue Cross and Blue Shield of Minnesota for Williams Arena), and state-backed economic development grants (notably $43M via DEED for a semiconductor tech center with Polar Semiconductor and Honeywell Aerospace). Its technology stack includes the AI-LEAF Institute ($20M USDA/NSF funded), a university-wide AI Hub launched in November 2025, AI-driven sepsis detection in partnership with M Health Fairview, and translational platforms advancing IND-stage therapeutics and specialty crop varieties.

Strategically, the university is executing the Elevate Extraordinary 2030 roadmap while absorbing material fiscal pressure from approximately $20.5M in House settlement athlete revenue-sharing obligations and a proposed FY2026-27 budget that eliminates around 165 positions and trims academic units by 3.8% ($43M). It is counterbalancing those pressures through aggressive expansion of corporate partnerships (biotech licensing, semiconductor workforce development, healthcare AI), creation of a Vice Provost for AI role, and monetization of athletic and research assets. Governance is provided by a 12-member Board of Regents with constitutional independence reaffirmed by the 1928 Minnesota Supreme Court Chase decision.

Name

Regents of The University of Minnesota

Legal name

Regents of the University of Minnesota

Website

https://regents.umn.edu

Company type

Private

Founded year

1851

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

The Regents of The University of Minnesota is the constitutionally autonomous governing body of a public, land-grant research university founded in 1851, operating five campuses statewide with 5,001–10,000 employees and a $5.4B proposed FY2026-27 budget, delivering education, research, healthcare, and licensed technologies across agriculture, biomedicine, microelectronics, and AI.

Ownership category

akta.pro rank

Product category

Higher Education

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (61131), Colleges, Universities, and Professional Schools (611310)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Public Research Universities with Multi-Campus Systems (EDAHAAAI)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Flagship Public Research Universities (R1/R2) (EDAHAAAA)

Keywords

• Higher education
• Research university
• Clinical trials
• Technology licensing
• Workforce development

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others, Infrastructure

Revenue model

1. Tuition and Fees: The university generates revenue through undergraduate and graduate tuition, with proposed 3.8% tuition increase for most undergraduates in FY2026-27 marking the sixth consecutive year of tuition hikes. Tuition rates are set by the Board of Regents.
2. State Appropriations: Public university funding from Minnesota state appropriations forms a significant portion of operating revenue, with the $5.4 billion operating budget for 2026-27.
3. Athletic Sponsorships and Naming Rights: 10-year naming rights deal with Blue Cross and Blue Shield of Minnesota for Williams Arena ($17 million total, $1.7 million per season). Revenue needed partly due to House settlement requirements to share money with athletes.
4. Research Grants and Clinical Trial Funding: External funding from biotech companies for clinical trials (e.g., $3.8M from GT Biopharma for nanobody therapy), federal grants (AI-LEAF Institute $20M from USDA/NSF), and licensing agreements.
5. DEED and Government Grants: Minnesota Forward Fund award through DEED for microelectronics and semiconductor tech center partnership with Polar Semiconductor and Honeywell Aerospace.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

The University of Minnesota is a public research institution operating five campuses (Crookston, Duluth, Morris, Rochester, and Twin Cities) that delivers undergraduate and graduate education, conducts research across agriculture, medicine, semiconductors, and AI, and provides healthcare services through clinical partnerships. The institution also generates revenue through athletic sponsorships, technology licensing, and corporate research partnerships.

Product overview

The Board of Regents website serves as the digital portal for the University of Minnesota's governing body, providing access to governance services, meeting materials, policy documentation, and public engagement tools. The Board operates through regular committee meetings (Academic Health, Audit & Compliance, Finance & Operations, Governance & Policy, Litigation Review, and Mission Fulfillment) and full Board sessions. Public participation is facilitated through the Board's Virtual Forum for comment submission and in-person attendance at meetings. The University also operates an AI Hub as a separate University-wide initiative focused on AI innovation and education under the Elevate Extraordinary 2030 strategic roadmap.

Differentiator

Problem solved

Functional benefit

Brands

• AI Hub: University-wide initiative to advance artificial intelligence innovation, education and workforce development across the state, led by inaugural Vice Provost for AI Dr. Galin Jones
• MN-Amber Oat Variety
• CounterXCL Platform

Products and services

• Board of Regents Governance Services
• Undergraduate and Graduate Education Programs
• AI Hub Initiative
• GTB-5550 Nanobody Therapy Clinical Trial
• CounterXCL Monoclonal Antibody Platform
• MN-Amber Oat Variety
• Microelectronics and Semiconductor Tech Center
• Bitternut Hickory Oil Research Program
• Williams Arena Naming Rights Partnership

Quantifiable outcome

• 260+ new jobs created through DEED Forward Fund partnerships
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and major.

• Blue Cross and Blue Shield of MinnesotacoreGTM or Marketing Partner · 12 June 202610-year naming rights sponsorship deal for Williams Arena (the Barn), renaming it 'the Barn by Blue Cross and Blue Shield of Minnesota.' Health insurance company headquartered in Eagan investing $17 million over the decade at $1.7 million per season. Deal comes as university faces pressure to raise revenue due to House settlement requirements to share money with athletes ($20.5M estimated for fiscal year).
• Polar SemiconductorcoreStrategic or Co-development Partner · 16 May 2026University partnering with Polar Semiconductor and Honeywell Aerospace on a microelectronics and semiconductor tech center. Part of $43 million DEED Minnesota Forward Fund award expected to create 260+ new jobs, retain 2,890+ positions, and leverage $693 million in outside investment.
• Honeywell AerospacecoreStrategic or Co-development Partner · 16 May 2026University partnering with Polar Semiconductor and Honeywell Aerospace on a microelectronics and semiconductor tech center. Part of $43 million DEED Minnesota Forward Fund award to support expansions and workforce training.
• GT BiopharmacoreStrategic or Co-development Partner · 7 April 2026Clinical trial agreement for phase 1a/1b trial of GTB-5550, a camelid nanobody therapy for advanced solid tumors. Company providing up to $3.8 million in funding over three years and submitted Investigational New Drug application to FDA for B7-H3 expressing solid tumor therapy.
• CounterX TherapeuticscoreStrategic or Co-development Partner · 10 March 2026Exclusive licensing agreement covering patents for monoclonal antibody and vaccine candidates targeting fentanyl and other synthetic opioids, along with CounterXCL platform technologies. Company planning to advance lead antibody candidate CTRX-101 into Phase 1 clinical trials in 2026.
• University of WashingtoncoreStrategic or Co-development Partner · 10 March 2026Joint exclusive licensing agreement with CounterX Therapeutics covering patents for monoclonal antibody and vaccine candidates targeting fentanyl and opioids, along with CounterXCL platform technologies.
• M Health FairviewcoreStrategic or Co-development Partner · 5 March 2026Clinical partnership with healthcare system for sepsis detection using AI technology. Builds on university's prior AI leadership including AI-LEAF Institute and ongoing health sciences initiatives.
• Minnesota State Government and PolicymakersmajorGTM or Marketing Partner · 5 March 2026AI Hub designed to align AI innovation with Minnesota's economic and workforce priorities. University collaborating with industry leaders and policymakers to drive statewide AI adoption and education.

Scale indicators14 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Michigan State University: Land-grant Big Ten peer with comparable agricultural research and plant breeding programs. Direct peer on land-grant mission, ag-tech IP portfolio, and multi-campus state-wide delivery model.
• Purdue University: Big Ten peer with strong STEM, semiconductor, and microelectronics research focus. Comparable on engineering scale, semiconductor workforce development, and applied industry partnerships.
• University of Wisconsin-Madison: Big Ten flagship public research university with similarly large research portfolio, multi-billion-dollar operating budget, land-grant heritage, and competing state appropriations model. Direct peer on scale, mission, and athletics footprint.
• University of Michigan: Top-tier public research university (R1) with extensive biomedical, AI, and engineering research, comparable operating scale, and Big Ten athletics. Closely comparable on research output, medical school complexity, and state-appropriated public university governance.
• University of Washington: Multi-campus public research university with co-licensing partnership on CounterXCL monoclonal antibody platform. Comparable in biomedical research depth, tech-transfer activity, and multi-campus structure (Seattle, Bothell, Tacoma).
• University of Iowa: Big Ten peer public research university with comparable medical school and clinical enterprise. Directly comparable in scale, Midwest regional mission, and Big Ten athletics economics including House settlement exposure.
• Ohio State University: Largest single-campus Big Ten public research university with similar $5B+ operating scale, comprehensive medical center, and major athletics revenue footprint. Closely comparable on budget scale, AMC complexity, and athletics economics.
• University of Illinois Urbana-Champaign: Big Ten peer with strong AI/engineering research, semiconductor and computer science leadership. Comparable on AI research positioning, tech-transfer portfolio, and public R1 scale.
• Penn State University: Land-grant, multi-campus Big Ten public research university with comparable statewide delivery model, agricultural research, and large athletics footprint including House settlement exposure.

Regional players

• Mayo Clinic: Minnesota-based clinical and research partner with overlapping biomedical research scope. Comparable as Rochester-anchored healthcare institution with deep clinical trial and translational research infrastructure overlapping with UMN.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Customer concentration

• YouTubeyoutube.com/channel/UC30Z0Nt2EZPL1R6x4zjpFOA

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regents of The University of Minnesota